Richard H Drew

5PUBLICATIONS
14CO-AUTHORS
Social epidemiologyIntensive careInfant and child healthPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 17, 2026
Economic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial.

|Dec 03, 2025
Comparison of cefazolin administered as a continuous or intermittent infusion for prophylaxis of surgical site infections in adult patients undergoing cardiac or neurologic surgery.

Richard H Drew, Nicholas A Turner, Elizabeth Keil

|Aug 02, 2023
Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).

Richard Drew, Ethan Brenneman, Jason Funaro

|Oct 09, 2019
Impact of select risk factors on treatment outcome in adults with candidemia.

Brandon Hill, Richard H Drew, Dustin Wilson

|Nov 13, 2018
Evaluation of a vancomycin dosing nomogram in obese patients weighing at least 100 kilograms.

Riley D Bowers, April A Cooper, Catherine L Wente

Pageof 1

Frequent Collaborators

2 joint publications

Nicholas A Turner

2 joint publications

Dustin Wilson

1 joint publications

Hui-Jie Lee

1 joint publications

David Gallagher